Literature DB >> 15345711

Reduced beta-amyloid production and increased inflammatory responses in presenilin conditional knock-out mice.

Vassilios Beglopoulos1, Xiaoyan Sun, Carlos A Saura, Cynthia A Lemere, Richard D Kim, Jie Shen.   

Abstract

Mutations in presenilins (PS) 1 and 2 are the major cause of familial Alzheimer's disease. Conditional double knock-out mice lacking both presenilins in the postnatal forebrain (PS cDKO mice) exhibit memory and synaptic plasticity impairments followed by progressive neurodegeneration in the cerebral cortex. Here we further investigate the molecular events that may underlie the observed phenotypes and identify additional neuropathological markers in the PS cDKO brain. Enzyme-linked immunosorbent assay analysis showed reduced levels of the toxic beta-amyloid (Abeta) peptides in the cerebral cortex of PS cDKO mice. Interestingly, the reduction in Abeta40 and Abeta42 peptides is similar in PS1 conditional knock-out and PS cDKO mice. We further examined the gene expression profile by oligonucleotide microarrays in the PS cDKO cerebral cortex and found that a high number of genes are differentially expressed, most notably a group of up-regulated inflammatory genes. Quantitative real-time reverse transcription PCR and Western analyses confirmed the elevated levels of glial fibrillary acidic protein, complement component C1q, and cathepsin S, up-regulation of which has been associated with inflammatory responses in various neurodegenerative processes. Immunohistochemical analysis revealed that the increase in complement component C1q is confined to the hippocampal formation, whereas glial fibrillary acidic protein and cathepsin S are up-regulated throughout the entire neocortex and hippocampus. In addition, strong microglial activation occurs in the hippocampus and the deeper cortical layers of PS cDKO mice. These results indicate that the memory impairment and neurodegeneration in PS cDKO mice are not caused by Abeta accumulation and that loss of PS function leads to differential up-regulation of inflammatory markers in the cerebral cortex.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15345711     DOI: 10.1074/jbc.M409544200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  69 in total

1.  Impaired neurotransmitter release in Alzheimer's and Parkinson's diseases.

Authors:  Jie Shen
Journal:  Neurodegener Dis       Date:  2010-02-18       Impact factor: 2.977

Review 2.  The amyloid-beta precursor protein: integrating structure with biological function.

Authors:  Constanze Reinhard; Sébastien S Hébert; Bart De Strooper
Journal:  EMBO J       Date:  2005-10-27       Impact factor: 11.598

Review 3.  Genetics, transcriptomics, and proteomics of Alzheimer's disease.

Authors:  Andreas Papassotiropoulos; Michael Fountoulakis; Travis Dunckley; Dietrich A Stephan; Eric M Reiman
Journal:  J Clin Psychiatry       Date:  2006-04       Impact factor: 4.384

4.  Presenilins regulate the cellular level of the tumor suppressor PTEN.

Authors:  Han Zhang; Runzhong Liu; Ruishan Wang; Shuigen Hong; Huaxi Xu; Yun-wu Zhang
Journal:  Neurobiol Aging       Date:  2007-01-12       Impact factor: 4.673

5.  Conditional forebrain inactivation of nicastrin causes progressive memory impairment and age-related neurodegeneration.

Authors:  Katsuhiko Tabuchi; Guiquan Chen; Thomas C Südhof; Jie Shen
Journal:  J Neurosci       Date:  2009-06-03       Impact factor: 6.167

6.  Presenilin 2 influences miR146 level and activity in microglia.

Authors:  Suman Jayadev; Amanda Case; Betty Alajajian; Alison J Eastman; Thomas Möller; Gwenn A Garden
Journal:  J Neurochem       Date:  2013-09-30       Impact factor: 5.372

7.  Catabolism of endogenous and overexpressed APH1a and PEN2: evidence for artifactual involvement of the proteasome in the degradation of overexpressed proteins.

Authors:  Julie Dunys; Toshitaka Kawarai; Sherwin Wilk; Peter St George-Hyslop; Cristine Alves da Costa; Frédéric Checler
Journal:  Biochem J       Date:  2006-03-01       Impact factor: 3.857

8.  Complement C3 deficiency protects against neurodegeneration in aged plaque-rich APP/PS1 mice.

Authors:  Qiaoqiao Shi; Saba Chowdhury; Rong Ma; Kevin X Le; Soyon Hong; Barbara J Caldarone; Beth Stevens; Cynthia A Lemere
Journal:  Sci Transl Med       Date:  2017-05-31       Impact factor: 17.956

9.  Design and characterization of a new cell-permeant inhibitor of the beta-secretase BACE1.

Authors:  Solveig Lefranc-Jullien; Vincent Lisowski; Jean-François Hernandez; Jean Martinez; Frédéric Checler
Journal:  Br J Pharmacol       Date:  2005-05       Impact factor: 8.739

10.  Oxidative damage increased in presenilin1/presenilin2 conditional double knockout mice.

Authors:  Dong-Li Zhang; Yi-Qun Chen; Xu Jiang; Ting-Ting Ji; Bing Mei
Journal:  Neurosci Bull       Date:  2009-06       Impact factor: 5.203

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.